©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 109767
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.109767
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.109767
Table 2 Seroprevalence of markers of occult hepatitis B infection in people on maintenance hemodialysis as reported in a few of the major studies (%)
| Ref. | Country | Number of participants | Proportion with seropositive status in unvaccinated HBsAg negative population | |||
| HBV DNA | IgG anti-HBc | Anti-HBs | IgG anti-HBc + anti-HBs | |||
| Siagris et al[22], 2006 | Greece | 49 | 20.4 | - | - | - |
| Yakaryilmaz et al[23], 2006 | Turkey | 188 | 2.7 | 6.4 | - | - |
| Aghakhani et al[24], 2010 | Iran | 289 | 50% of IgG anti-HBc reactive | 6.2 | - | - |
| Mina et al[25], 2010 | Greece | 346 | 0.9 | - | - | - |
| Helaly et al[26], 2015 | Egypt | 100 | 45.8% of IgG anti-HBc positive group | 48 | - | - |
| Sowole et al[27], 2015 | United Kingdom | 778 | - | 3 | - | 17 |
| Kalantari et al[28], 2016 | Iran | 400 | - | 2.5 | - | 5.5 |
| Tang et al[29], 2020 | China | 330 | - | 10.8 | - | 48 |
| Farshadpour et al[30], 2023 | Iran | 274 | 11.7 | 24.1 | - | - |
- Citation: Singh S, Singh R, Kaul A, Goel A. Hepatitis B and chronic kidney disease: Bench to bedside. World J Nephrol 2025; 14(4): 109767
- URL: https://www.wjgnet.com/2220-6124/full/v14/i4/109767.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i4.109767